Bill > H1129

This bill, titled "Providing a right to try," aims to authorize terminally ill patients to consent to treatment with investigational drugs, biological products, or devices that have successfully completed Phase 1 of a clinical trial but are not yet approved for general use by the U.S. Food and Drug Administration (FDA). The key provisions of the bill include: defining an "eligible patient," outlining the requirements for written, informed consent, allowing manufacturers to provide investigational products to eligible patients, clarifying that the bill does not expand insurance coverage requirements, protecting healthcare providers from disciplinary action for recommending investigational treatments, and shielding manufacturers and others involved in the patient's care from liability for harm resulting from the use of the investigational product, provided they comply with the terms of the bill.

Health and Social Services

https://malegislature.gov/Bills/190/H1129